Australia Flags Unapproved Peptides as Online Sales Drive Enhancement Use

3 articles · Updated · The Conversation · Jul 7

Online vendors and influencers are pushing injectable peptides for weight loss, muscle growth, tanning and anti-ageing, moving the substances from niche fitness circles into mainstream attention.
Many products sold in Australia — including BPC-157, retatrutide and TB-500 — lack Therapeutic Goods Administration approval, making their import or supply for human use unlawful without authorization.
Laboratory testing found some retatrutide doses were nearly 2 times the label claim, underscoring broader risks from mislabeling, contamination and unknown effects because most enhancement peptides have little or no human trial data.
Injection adds infection, abscess, scarring and blood-borne virus risks, while users often do not disclose peptide use to health services and may miss harm-reduction advice.
Australia has no routine surveillance of peptide use, prompting calls for tighter enforcement of online marketing rules, better clinician education and research into the wider enhancement ecosystem.

Sources

The Conversation2d ago

Injectable Peptides Gain Mainstream Attention for Enhancement, Raising Regulatory and Safety Concerns

NPR2d ago

What's behind the push to make peptide therapies more readily available : NPR

WVIA Public Media2d ago

What's behind the push to make peptide therapies more readily available

4 Sources

A new drug shows record weight loss in trials. Why are people risking their lives injecting unregulated versions from the internet?

Influencers sell a 'better you' with illegal injections. Are social media platforms now legally responsible for the fallout?

Australia’s Peptide Crisis: TGA Declares Unapproved Peptides a Critical Compliance Priority for 2026–27 Amidst Online Surge and Health Risks

Overview

Australia is facing a sharp rise in the use of unapproved peptide products, leading the Therapeutic Goods Administration (TGA) to make peptides a top compliance priority for 2026–27. The TGA’s new Compliance Principles, released in January, highlight peptides as a key focus area, with regular reviews every three months. This action responds to growing concerns about the spread and misuse of peptides, many of which are marketed online as 'Chinese research chemicals' and sold directly to consumers. The TGA’s intensified focus aims to address these risks and protect public health from unregulated substances.

...